PSP-006

N/A

Report date: 2024/02/02 17:52:12

Base Information

Drug NamePSP-006
Drug Alias NamePSP-006
ClassificationBiologics > Protein drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsThrombocytopenia, Neonatal Alloimmune
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesProsit Sole Biotechnology (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesProsit Sole Biotechnology (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsThrombocytopenia, Neonatal Alloimmune
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A